Chargement en cours...
Thrombin generation in newly diagnosed multiple myeloma during the first three cycles of treatment: An observational cohort study
BACKGROUND: Multiple myeloma (MM) is associated with a high risk of thrombosis, particularly during the first months of treatment including immunomodulatory drugs (IMiDs). There is no consensus on prevention of thromboembolic risk in patients with de novo MM, and identification of patients requiring...
Enregistré dans:
| Publié dans: | Res Pract Thromb Haemost |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6332829/ https://ncbi.nlm.nih.gov/pubmed/30656281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12161 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|